Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1984-9-26
|
| pubmed:abstractText |
NG-Monoethyl-L-arginine, a putative in vivo product after administration of the potent hepatocarcinogen L-ethionine to rats, has been chemically synthesized by coupling N-ethyl, S- methylthiopseudouronium iodide with alpha-amino-blocked L-ornithine. The structure of the compound as NG-monoethyl-L-arginine was confirmed by 13C NMR. Its elution time on an automatic amino acid analyzer, Rf values using thin-layer chromatography, and isoelectric point have been compared with those of NG-monomethyl-L-arginine.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0003-2697
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
139
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
377-82
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading | |
| pubmed:year |
1984
|
| pubmed:articleTitle |
Preparation of Ng-Monoethyl-L-arginine.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|